Fingerprint
Dive into the research topics of 'Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically